SCHEMBL4044221

SCHEMBL4044221

CC(=O)OCCOc1ccc(C(C)C(=O)O)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 2/20 0.39
PDE3A Q14432 2/20 0.39
P2RY12 Q9H244 2/20 0.39
HTT P42858 1/20 0.38
CYP4F2 P78329 4/20 0.38
CYP4A11 Q02928 4/20 0.38
APP P05067 1/20 0.37
ACACB O00763 1/20 0.37
MAPK1 P28482 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
CACNA1I Q9P0X4 2/20 0.34
CACNA1G O43497 1/20 0.34
CACNA1H O95180 1/20 0.34
CNR2 P34972 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15764197 0.83 PDE3B (0.39) PDE3BPDE3AP2RY12HTTCYP4F2
SCHEMBL4034400 0.82 PDE3B (0.39) PDE3BPDE3AP2RY12HTTCYP4F2
SCHEMBL4034397 0.82 PDE3B (0.40) PDE3BPDE3AP2RY12HTTAPP
SCHEMBL28904650 0.76 MAPT (0.51) PDE3BPDE3AP2RY12HTTAPP
SCHEMBL30026033 0.76 MAPT (0.51) PDE3BPDE3AP2RY12HTTAPP
SCHEMBL2194940 0.76 NFE2L2 (0.47) ACACB
SCHEMBL3306252 0.75 PDE3B (0.43) PDE3BPDE3AP2RY12HTTAPP
SCHEMBL3306255 0.75 PDE3B (0.43) PDE3BPDE3AP2RY12HTTAPP
SCHEMBL10030181 0.75 L3MBTL1 (0.55) PDE3BPDE3AP2RY12LMNATP53
SCHEMBL3300820 0.74 PDE3B (0.42) PDE3BPDE3AP2RY12HTTCYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066637-A1 NOVEL SUBSTITUTED BIPYRIDINE DERIVATIVES AND THEIR USE AS ADENOSINE RECEPTOR LIGANDS Bayer HealthCare AG (DE) 2009-06-10 EP disclosed
WO-2008028590-A1 NOVEL SUBSTITUTED BIPYRIDINE DERIVATIVES AND THEIR USE AS ADENOSINE RECEPTOR LIGANDS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-13 WO disclosed